Back to results
US 2008/0269503 A1Published application
Processes for preparing darifenacin hydrobromide
AssigneesTeva Pharmaceuticals USA, Inc. for Barbados, Teva Pharmaceutical Industries Ltd.
InventorsValeriano Merli, Augusto Canavesi, Paola Daverio
Life of this patent
Estimating the term…
Abstract
The invention encompasses processes for the preparation of darifenacin hydrobromide.
Claims6
A process for preparing darifenacin hydrobromide comprising:
- a) combining 3-(S)-(+)-hydroxypyrrolidine, a solvent selected from the group consisting of a C6-9 aromatic hydrocarbon, a polar aprotic organic solvent, and mixtures thereof, a sulfonyl halide, and a base to obtain 1-X-sulfonyl-3-(S)-(−)-X-sulfonyloxypyrrolidine of formula I,
- b) reacting the 1-X-sulfonyl-3-(S)-(−)-X-sulfonyloxypyrrolidine of formula I, diphenylacetonitrile, and an inorganic base, in an organic solvent selected from the group consisting of a C6-9 aromatic hydrocarbon, a polar aprotic organic solvent, and mixtures thereof, to obtain (S)-2,2-diphenyl-2-(1-X-sulfonyl-3-pyrrolidinil)acetonitrile of formula II;
- c) reacting the (S)-2,2-diphenyl-2-(1-X-sulfonyl-3-pyrrolidinil)acetonitrile intermediate of formula II, a bromine acceptor selected from the group consisting of phenol and naphthol, and an acid to obtain (S)-2,2-diphenyl-2-(3-pyrrolidinil) acetonitrile salt of formula III,
- wherein the bromine acceptor is phenol only when the acid is HBr;
- d) combining the (S)-2,2-diphenyl-2-(3-pyrrolidinil)acetonitrile salt of formula III, a compound of the formula V,
- a solvent selected from the group consisting of a C6-9 aromatic hydrocarbon, a polar organic solvent, water, and mixtures thereof, and a base to obtain a mixture;
- e) heating the mixture of step d;
- f) admixing the mixture of step d with an acid to obtain a (S)-2-{1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-acetonitrile salt of formula IV;
- and
- g) admixing the (S)-2-{1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-acetonitrile salt of formula IV, an inorganic base and a protic solvent;
- and
- h) reacting with hydrobromic acid to obtain darifenacin hydrobromide, wherein X is either C1-10 alkyl or C6-9 aryl, wherein Y is a leaving group selected from the group consisting of I, Cl, Br, mesyl, tosyl, brosyl, trifluoroacetyl, and trifluoromethansulfonyl, wherein Z1 and Z2 are independently an acid.
9 more elements
Dependencies are inferred from the claim text.